Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers

British Journal of Cancer

Volumn 90, Issue 12, 2004, Pages 2378-2383

  Lee, Y C ^a   Wu, C T ^a   Shih, J Y ^a   Jou, Y S ^b   Chang, Y L ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c Department of Nuclear Safety   (Taiwan)

Author keywords

FHIT; Loss of heterozygosity; Lung cancers

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P53; ACID ANHYDRIDE HYDROLASE; MICROSATELLITE DNA; TUMOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE FREQUENCY; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICRODISSECTION; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; ALLELE; BIOSYNTHESIS; ETHNOLOGY; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; TAIWAN; UPREGULATION;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; SEX FACTORS; TAIWAN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 3042743715     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601778     Document Type: Article

References (37)

1. An Q, Liu Y, Gao Y, Huang J, Fong X, Liu L, Zhang D, Zhang J, Cheng S (2002) Deletion of tumour suppressor genes in Chinese non-small cell lung cancer. Cancer Lett 184: 189-195
2. Burke L, Khan MA, Freedman AN, Gemna A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC (1998) Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res 58: 2533-2536
3. Chang YL, Wu CT, Shih JY, Lee YC (2003) Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers. Br J Cancer 89: 320-326
4. Chen CJ, Wu HY, Chuang YC, Chang AS, Luh KT, Chao HH, Chen KY, Chen SG, Lai GM, Huang HH (1990) Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res 10: 971-976
5. Croce CM, Sozzi G, Huebner K (1999) Role of FHIT in human cancer. J Clin Oncol 17: 1618-1624
6. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassoal FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT CDNA splicing aberrations. Cancer Res 57: 2256-2267
7. Garinis GAa, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C (2001) Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). J Pathol 193: 55-65
8. Gayther SA, Barski P, Batley SJ, Li L, de Foy KA, Cohen SN, Ponder BA, Caldas C (1997) Aberrant splicing of the TSG 101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Oncogene 15: 2119-2126
9. Geradts J, Fong KM, Zimmerman PV, Minna JD (2000) Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features. Br J Cancer 82: 1191-1197
10. Ihde DC, Minna JD (1991) Non-small cell lung cancer. Part I: biology, diagnosis, and staging. Curr Probl Cancer 15: 65-147
11. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA (1999) Induction of apoptosis and inhibition of tumorigenicity and tumour growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res 59: 3333-3339
12. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-171
13. ARF genes in nasopharyngeal carcinoma. Cancer 94: 1987-1996
14. Lee YC, Wu CT, Chen JS, Hsu HH, Chang YL (2002) The significance of E-cadherin and α-, β-, and γ-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size. J Thorac Cardiovasc Surg 123: 502-506
15. Marchetti A, Pellegrini S, Bertacca G, Buttitta F, Gaeta P, Carnicelli V, Nardini V, Griseri P, Chella A, Angeletti CA, Bevilacqua G (1998) FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. J Pathol 184: 240-246
16. Mountain CF (2002) Staging classification of lung cancer. A critical evaluation. Clin Chest Medic 23(1): 103-121
17. Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT (1998) Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 58: 1804-1807
18. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597
19. Petursdottir TE, Hafsteinsdottir SH, Jonasson JG, Moller PH, Thorsteinsdottir U, Huiping C, Egilsson V, Ingvarsson S (2002) Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients. Anticancer Res 22: 3205-3212
20. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112-126
21. Pylkkanen L, Wolff H, Stjernvall T, Tuominen P, Sioris T, Karjalainen A, Anttila S, Husgafvel-Pursiainen K (2002) Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients. Int J Oncol 20: 285-290
22. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce CM, Pierotti M, Sozzi (1999) The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 96: 8489-8492
23. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K (1997) Replacement of FHIT in cancer cells suppressed tumorigenicity. Proc Natl Acad Sci USA 94: 13771-13776
24. Slaughter M, Skejkal W (1953) Field cancerisation in oral stratified epithelium: clinical implications of multicentric origin. Cancer (Phila) 6: 963-968
25. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85: 17-26
26. Sozzi G, Sard L, De Gregonio L, Marchetti A, Musso K, Buttita F, Tornielli S, Pellegrini S, Veronese ML, Manenti G, Incarbone M, Chella A, Angeletti CA, Pastorino U, Huebner K, Bevilaque G, Pilotti S, Croce CM, Pierotti MA (1997) Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 57: 2121-2123
27. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58: 5032-5037
28. Sozzi G, Oggionni M, Alasio L, Conte D, Tavecchio L, Pilotti S, Spinelli P, Calarco G (2002) Molecular changes track recurrence and progression of bronchial precancerous lesions. Lung Cancer 37: 267-270
29. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamure M, Ishizaki K (1998) Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58: 3429-3434
30. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou JY, Taguchi T, Keller SM (1994) Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosomes Cancer 11: 178-194
31. Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J (1998) Clinicopathological significance of FHIT protein expression in stage I non-small cell lung carcinoma. Cancer Res 58: 5478-5830
32. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T (1992) Allelotype of non-small cell lung carcinomas - comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52: 2478-2481
33. Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T (1996) Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res 56: 5579-5582
34. Yokota J, Sugimura T (1993) Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 7: 920-925
35. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rudiger T, McCue PA, Croce CM, Huebner K (2001) The tumour spectrum in FHIT-deficient mice. Proc Natl Acad Sci USA 98: 10250-10255
36. Zienolddiny S, Ryberg D, Arab MO, Skaug V, Haugen A (2001) Loss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer 84: 226-231
37. Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD (2001) 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 61: 3581-3585